Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

28 April 2015

Launch Avycaz by Actavis in US markets to treat cIAI and complicated urinary tract infections

In the United States, Actavis plc, global pharmaceutical company, has launched Avycaz (ceftazidime-avibactam) to treat adult patients with complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible bacteria, including certain Enterobacteriaceae and Pseudomonas aeruginosa. Avycaz should be reserved for use in patients who have limited or no alternative treatment options.
- Read more about Egg White Can Help Make Antibacterial Bioplastic
Bioplastics made from protein sources such as egg albumin and whey may have significant antibacterial properties, scientists, including those of Indian-origin, have found. The findings could eventually lead to their application in plastics used in medical applications such as wound healing dressings, sutures, catheter tubes and drug delivery. The bioplastic materials could also be used for food packaging, researchers said.

[adsense:336x280:8701650588]
- Read more about Mylan launches in India generic sofosbuvir 400 mg tablets to treat chronic hepatitis C
Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., has launched generic sofosbuvir 400 mg tablets under the brand name MyHep in India. The product is used for the treatment of chronic hepatitis C,which is a long-lasting infection with the hepatitis C virus. Chronic hepatitis C is a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.
- Read more about B Jain Pharma introduces guateria guameri, homoeopathic drug for cholesterol
B Jain Pharmaceuticals, the leading manufacturer and distributor of homoeopathic medicines, introduced its latest product - guateria guameri, for bringing down cholesterol. The medicine is effective in treating hyperlipilidemia, which is a risk factor for cardiovascular disease.
- Read more about Mauna Kea Technologies inventor of Cellvizio receives Mexican approval
Mauna Kea Technologies, inventor of Cellvizio, the multidisciplinary confocal laser endomicroscopy platform, has received regulatory approval from COFEPRIS (Comisión Federal Para la Protección contra Riesgos Sanitarios), the Mexican health authority, for the commercialization of Cellvizio.. Mauna Kea Technologies is now able to implement its marketing strategy with its partner, Endomédica, a company specialized in the fields of interventional endoscopy, gastroenterology, urology and surgery since 1986.
- Read more about Syneron Medical's PicoWay picosecond laser approved by USFDA to treat pigmented lesions
Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, announced today that the PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for the treatment of pigmented lesions.
- Read more about Piramal Imaging pleased to support study on assessing value of PET scans in Alzheimer’s disease and Dementia Diagnosis
Piramal Imaging is honoured to announce it will provide funding and support, along with other industry partners, for a major clinical study titled, "Imaging Dementia – Evidence for Amyloid Scanning" (IDEAS). The trial is designed to evaluate the impact of positron emission tomography (PET) scanning of beta-amyloid deposits in the diagnosis of Alzheimer’s disease (AD) and Dementia in a defined patient population.
- Read more about For heart disease research Chennai based Lifeline Hospital join hands with Russia
The Chennai based Frontier Lifeline Hospital (FLL) and The Institute for Atherosclerosis Research, Moscow in Russia, merge for a collaborative research agreement to study the ‘genetic similarities causing heart diseases in Russians & Indians’.
- Read more about Merck Collaborates with Maharashtra University to Build Diabetes and Hypertension Healthcare Capacity India
Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing European Accredited Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.
23 April 2015

Lupin introduce Zaxine in Canada for liver disease treatment

Pharma Major Lupin’s Canadian subsidiary, Lupin Pharma Canada has launched its first Brand product Zaxine under a strategic licensing agreement with the North Carolina based GI specialty company Salix Pharmaceuticals Inc. The agreement grants Lupin exclusive rights to promote, distribute and market Zaxine in the Canada.